Technical Analysis for ACET - Adicet Bio, Inc.

Grade Last Price % Change Price Change
B 11.5 -0.26% -0.03
ACET closed down 3.51 percent on Thursday, January 27, 2022, on 8 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical ACET trend table...

Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness -0.26%
Strong but Oversold Other -0.26%
Wide Bands Range Expansion -0.26%
Down 3 Days in a Row Weakness -0.26%
Oversold Stochastic Weakness -0.26%
1,2,3 Retracement Bearish Bearish Swing Setup -3.77%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.77%
Outside Day Range Expansion -3.77%
Wide Bands Range Expansion -3.77%
Oversold Stochastic Weakness -3.77%
Older End-of-Day Signals for ACET ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 1 minute ago
Up 3% about 2 hours ago
60 Minute Opening Range Breakout about 2 hours ago
Down 1% about 3 hours ago
Fell Below Previous Day's Low about 4 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Immune System Antibodies Cancer Immunotherapy Therapies For Cancer Immune Response Chimeric Antigen Receptor Chimeric Antigen Receptor T Cell T Cell Adoptive Cell Transfer Antigen

Is ACET a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.49
52 Week Low 6.25
Average Volume 1,480,063
200-Day Moving Average 10.63
50-Day Moving Average 13.45
20-Day Moving Average 14.58
10-Day Moving Average 12.86
Average True Range 1.21
ADX 31.21
+DI 11.20
-DI 25.40
Chandelier Exit (Long, 3 ATRs) 14.87
Chandelier Exit (Short, 3 ATRs) 14.75
Upper Bollinger Bands 18.56
Lower Bollinger Band 10.59
Percent B (%b) 0.12
BandWidth 54.69
MACD Line -0.63
MACD Signal Line -0.16
MACD Histogram -0.4722
Fundamentals Value
Market Cap 226.32 Million
Num Shares 19.6 Million
EPS
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.82
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.13
Resistance 3 (R3) 13.28 12.90 12.86
Resistance 2 (R2) 12.90 12.49 12.82 12.77
Resistance 1 (R1) 12.21 12.24 12.02 12.06 12.68
Pivot Point 11.83 11.83 11.74 11.76 11.83
Support 1 (S1) 11.15 11.42 10.96 11.00 10.38
Support 2 (S2) 10.77 11.17 10.69 10.29
Support 3 (S3) 10.08 10.77 10.20
Support 4 (S4) 9.93